Lebrikizumab

From Self-sufficiency
Jump to: navigation, search
Lebrikizumab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target IL-13
Identifiers
CAS Number 953400-68-5
ATC code none
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Lebrikizumab is a humanized monoclonal antibody and an immunosuppresive drug for the treatment of asthma. As of September 2009, it is undergoing Phase II clinical trials.[1][2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. ClinicalTrials.gov
  2. Genentech: Lebrikizumab (anti-IL13)